Skip to main content

Amanda Rodríguez Urrutia

Graduated in Medicine and Surgery at the University of Barcelona (UB) in 2002, obtaining the specialization in psychiatry via MIR. Since 2007 I work as a specialist physician at the Mental Health Service of the hospital. Currently I coordinate the Resistant Depression Program of the Mental Health Service of the Vall d'Hebron University Hospital.

Institutions of which they are part

Main researcher
Psychiatry, Mental Health and Addictions
Vall Hebron Institut de Recerca
Psychiatrics
General Hospital

Amanda Rodríguez Urrutia

Institutions of which they are part

Main researcher
Psychiatry, Mental Health and Addictions
Vall Hebron Institut de Recerca
Psychiatrics
General Hospital

Graduated in Medicine and Surgery at the University of Barcelona (UB) in 2002, obtaining the specialization in psychiatry via MIR. Since 2007 I work as a specialist physician at the Mental Health Service of the hospital. Currently I coordinate the Resistant Depression Program of the Mental Health Service of the Vall d'Hebron University Hospital.

PhD in Psychiatry from the Universitat Autònoma de Barcelona (UAB) in 2017 with the qualification of excellent cum laude and extraordinary award. I am very interested in teaching, I am an associate professor at the Faculty of Medicine, coordinator of tutors of residents and tutor since 2013. Since 2018 I am part of the Hospital Ethics Committee. My main line of research is focused on the dysfunctions of the Brain-Immune-Gut axis and depression. I lead the implementation of the Brain-Immune-Gut line at VHIR together with other groups. I am part of national and international grants (discoverie.eu).

Research lines

Brain-Immune-Gut

IP: Amanda Rodríguez Urrutia

Projects

Active Comparator-controlled, Clinical Trial to Study the Efficacy and Safety of the INtegral Cognitive REMediation program (INCREM) in patients with Depression.

IP: Amanda Rodríguez Urrutia
Collaborators: Natalia Calvo Piñero, Montserrat Corrales De la Cruz, Gemma Nieva Rifa, Julia Vendrell Serres, Sara García González
Funding agency: Fundació La Marató de TV3
Funding: 60872.31
Reference: 202227-30-31-32-33
Duration: 30/04/2023 - 30/04/2026

Grup consolidat

IP: José Antonio Ramos Quiroga
Collaborators: Pilar Lusilla Palacios, Natalia Calvo Piñero, Amanda Rodríguez Urrutia, Montserrat Corrales De la Cruz, Judit Cabana Dominguez, Marc Ferrer Vinardell, Gemma Nieva Rifa, Mª Dolores Braquehais Conesa, Lara Grau Lopez, Constanza Daigre Blanco, Marta Ribases Haro, Laura Gisbert Gustemps, Vanesa Richarte Fernández, Mireia Forner Puntonet, Christian Fadeuilhe Grau, Francisco Collazos Sanchez, Silvia Alemany Sierra, Silvia Amoretti Guadall, Gara Arteaga Henriquez, Natalia Llonga Tejedor, Maria Soler Artigas, Jorge Lugo Marin
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 60000
Reference: 2021 SGR 00840
Duration: 01/01/2022 - 30/06/2025

Development, dIagnostic and prevention of gender-related Somatic and mental COmorbitiEs in IRritable bowel syndrome In Europe (DISCOvERIE)

IP: Fco Javier Santos Vicente
Collaborators: Beatriz Lobo Alvarez, Silvia Muñoz Caller, Carmen Alonso Cotoner, Ana Maria Gonzalez Castro, Elba Exposito Fernandez, Marc Pigrau Pastor, Xavier Serra Ruiz, Adoración Nieto Ruiz, Alejandro Henao Paez, Consuelo Cammarota, José Alegre Martin, Jesus Castro Marrero, Marta Ribases Haro, Natalia Llonga Tejedor, Amanda Rodríguez Urrutia
Funding agency: EUROPEAN COMMISSION
Funding: 1148684.84
Reference: DISCOVERIE_H2020-SC1-BHC2019
Duration: 01/01/2020 - 31/12/2024

NEUROFISIOLOGIA Y NEUROFISIOPATOLOGIA DIGESTIVA

IP: Fernando Azpiroz Vidaur
Collaborators: Amanda Rodríguez Urrutia, Joan Dot Bach, Monder Abu-Suboh Abadia
Funding agency: Ministerio Economía, Industria y Competitividad
Funding: 314600
Reference: SAF2016-76648-R
Duration: 30/12/2016 - 30/06/2021

Related news

Irritability in ADHD and BDP is an understudied symptom that has a major impact on patients' quality of life and may even increase the risk of suicide.

These results reinforce the need for more individualized attention to address educational needs from an early stage.

On World Clinical Trials Day, we highlight some of the studies we have participated in that confirm the efficacy of new drugs, allowing their approval by regulatory agencies.

Related professionals

Elena Lopez Cancio Martínez

Elena Lopez Cancio Martínez

Postdoctoral researcher
Neurovascular Diseases
Read more
Rocío Piñera Moreno

Rocío Piñera Moreno

Research assistant
Gene and Cell Therapy
Read more
Joana Margalida Cladera  Sastre

Joana Margalida Cladera Sastre

Research technician
Neurodegenerative Diseases
Read more
Kushal Mukesh Lakhani Mahtani

Kushal Mukesh Lakhani Mahtani

Predoctoral researcher
Reconstructive Surgery of the Locomotor System
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.